| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10917952 | Radiotherapy and Oncology | 2015 | 6 Pages |
Abstract
Supported by this large multicentric series, both SRS and FSRT can be recommended for the treatment of VS. SRS application is limited by tumor size, and is associated with a steep dose-response-curve. When chosen diligently based on tumor volume, pre-treatment characteristics and volume-dependent dose-prescription in SRS (⩽13 Gy), both treatments may be considered equally effective.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Stephanie E. Combs, Christina Engelhard, Christine Kopp, Nicole Wiedenmann, Oliver Schramm, Vesna Prokic, Jürgen Debus, Michael Molls, Anca-Ligia Grosu,